arrow
G

Georg A. Böhmig

Medical University of Vienna
H指数:51
被引数:9,593

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A multicenter registry study of the CD38 antibody daratumumab for the treatment of microvascular inflammation following kidney transplantation

CD38抗体达拉木单抗治疗肾移植后微血管炎的多中心注册研究

2026-07-230
OA
Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study

克 Lazakizumab 在慢性活动性抗体介导的肾移植排斥反应治疗中的应用:IMAGINE III 期、随机、双盲、安慰剂对照研究的结果

2026-04-240
OAAI
The Banff 2024 Kidney Meeting Report: Rejection as a spectrum of phenotypes and focus on differential diagnostic reasoning

Banff 2024 肾脏会议报告:排斥反应作为一种表型谱及关注鉴别诊断推理

2026-03-050
OAAI
DARC and Anti-Duffy Antibodies in the Line of Fire: The Challenges in Pinpointing the Etiology of Microcirculation Inflammation to a Distinct Entity

DARC和抗 Duffy 抗体在炎症前沿:将微循环炎症的病因明确归因于特定实体的挑战

2026-01-120
OA
NK cell missing self in microvascular inflammation with and without donor-specific antibodies

NK细胞在微血管炎症中的缺失自我识别,以及有无供者特异性抗体的情况

2026-01-010
PRE
Continuous indices to assess the phenotypic spectrum of kidney transplant rejection

连续性指标用于评估肾移植排斥反应的表型谱

2025-11-260
OAAI
Effect of felzartamab anti-CD38 treatment on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies

Felzartamab抗CD38治疗对肾移植活检中抗体介导排斥反应分子表型的影响

2025-10-010
PRE
Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus

使用伊米非单抗进行HLA不兼容 deceased donor 肾移植的脱敏处理:一项德尔菲国际专家共识

2025-01-061
OA
Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants-a prospective cohort study (RESCUE-TX)
2024-11-010
OAAI